Global Stem Cells Group Announces An Agreement With ROKIT Healthcare
Global Stem Cells Group announces an agreement with a professional South Korean biotechnology giant. The name of its giant is Rokit Healthcare to represent the technology of the company in the Latin American market.
The GSCG is among the world leaders of regenerative medicine technologies. Now, the GSCG has signed an agreement with South Korean-based Rokit healthcare. Rokit healthcare is an esteemed bioprinter manufacturer that is helping in advancing the field of regen medicine.
The bioprinting field is new, yet it provides great opportunities. It is an automated, computer-aided deposition of bio-materials to manufacture the functional human tissues or organs. They harvest the growth factors and use them with an exclusive printing facility to create regenerative damage. Rokit healthcare does this mostly through the proliferation of a machine that they dub an ‘organ regenerator.’ The organ regeneration looks like a three-D printer. Yet, in this printer, cells are safely used to implant within the body.
The process of three-Dimensional bioprinting is a new technology in the field of tissue engineering. But there are a lot of challenges in this field as well. Among these challenges is the mimicking of the micro and macro environment of human tissue. To prevent this problem, several advances in additive manufacturing are made. Due to this, certain scientists in Korea have become inspired to develop novel bioprinting technology.
Due to the advances in three-dimensional printing and regenerative medicine, the spreading of bioprinting technology is limitless. Efforts are being made to use the four-dimensional printing of the patients.
The invivo four-dimensional printer is a flagship product of Rokit Healthcare. This product revolutionizes the application of growth factor-based therapies and regen medicine. The GSCG is also trying to combine three-dimensional and bioprinting technologies. This way, they can distribute a patient’s cells more efficiently.
“We’re highly excited about this new opportunity and look forward to working with Rokit,” Says Benito Novas, CEO of the Global Stem Cells Group, “The Invivo 4D Printer is in a position to turn the practice of regenerative medicine onto its head, and we are planning on creating a training center in Cancun, Mexico exclusively to showcase and instruct other physicians in this cutting-edge technology,”
About Global Stem Cells Group
Global Stem Cells Group Is A Worldwide network that combines several medical corporations. These corporations focus on improving the scientific and technological advancements to lead cutting-edge stem cell research, training, and treatments. The efforts of GSCG provide medical practitioners with a one-stop hub for regenerative medicine solutions.
Rokit healthcare is a global healthcare company that provides a practical and autologous organ regenerative platform. To complete this task, the company uses proprietary fabrication technologies that promise to treat various diseases in this field due to this proliferation of four-dimensional bioprinting technology, autologous stem cell technologies. Rokit healthcare believes that supplying an avenue for organ regeneration will drastically reduce and change how everyday people trust and manage their fitness and body.